BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 7687134)

  • 1. Use and toxicity of the colony-stimulating factors.
    Schriber JR; Negrin RS
    Drug Saf; 1993 Jun; 8(6):457-68. PubMed ID: 7687134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Southwestern Internal Medicine Conference: clinical use of hematopoietic growth factors.
    Fleischman RA
    Am J Med Sci; 1993 Apr; 305(4):248-73. PubMed ID: 7682752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hematopoietic growth factors].
    Robak T
    Postepy Hig Med Dosw; 1991; 45(6):461-96. PubMed ID: 1726024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical applications of colony-stimulating factors.
    Groopman JE
    Semin Oncol; 1988 Dec; 15(6 Suppl 6):27-33. PubMed ID: 2462748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-CSF and GM-CSF in clinical trials.
    Antman KH
    Yale J Biol Med; 1990; 63(5):387-410. PubMed ID: 1705737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in the management of cancer.
    Fan D; O'Brian CA; Ioannides CG; Clyne RK
    In Vivo; 1991; 5(6):571-7. PubMed ID: 1810441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colony-stimulating factors: a new step in clinical practice. Part I.
    Nemunaitis J
    Ann Med; 1992 Dec; 24(6):439-44. PubMed ID: 1485935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic colony-stimulating factors.
    Kaushansky K; Brown CB; Petersdorf S
    Biotechnology; 1991; 19():365-95. PubMed ID: 1723913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colony-stimulating factors for the management of neutropenia in cancer patients.
    Dale DC
    Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current status of the clinical application of hematopoietic growth factors in oncology].
    Karthaus M; Ganser A
    Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical applications of recombinant human colony-stimulating factors.
    Klingemann HG
    CMAJ; 1989 Jan; 140(2):137-42. PubMed ID: 2642725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion.
    Möhle R; Kanz L
    Semin Hematol; 2007 Jul; 44(3):193-202. PubMed ID: 17631183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of human granulocyte-macrophage colony-stimulating factor.
    Sakamoto KM; Gasson JC
    Int J Cell Cloning; 1991 Nov; 9(6):531-41. PubMed ID: 1770227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colony-stimulating factors.
    Gordon MS; Gabrilove JL
    Curr Opin Oncol; 1990 Dec; 2(6):1152-8. PubMed ID: 1712236
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical use of colony stimulating factors.
    Moore MA
    Annu Rev Immunol; 1991; 9():159-91. PubMed ID: 1910675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future strategies in the control of myelosuppression: the use of colony-stimulating factors.
    Haeuber D
    Oncol Nurs Forum; 1991 Mar; 18(2 Suppl):16-21. PubMed ID: 2047296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cells.
    Herrmann F; Brugger W; Kanz L; Mertelsmann R
    Semin Oncol; 1992 Aug; 19(4):422-31. PubMed ID: 1380732
    [No Abstract]   [Full Text] [Related]  

  • 20. Recommendations on the use of colony-stimulating factors in children: conclusions of a European panel.
    Schaison G; Eden OB; Henze G; Kamps WA; Locatelli F; Ninane J; Ortega J; Riikonen P; Wagner HP
    Eur J Pediatr; 1998 Dec; 157(12):955-66. PubMed ID: 9877032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.